APA (7th ed.) Citation

IK, U., BA, S., JS, R., KG, K., & PJF, R. (2022). Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines. Frontiers in molecular biosciences, 9, 832393. https://doi.org/10.3389/fmolb.2022.832393

Chicago Style (17th ed.) Citation

IK, Uche, Stanfield BA, Rudd JS, Kousoulas KG, and Rider PJF. "Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines." Frontiers in Molecular Biosciences 9 (2022): 832393. https://doi.org/10.3389/fmolb.2022.832393.

MLA (9th ed.) Citation

IK, Uche, et al. "Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines." Frontiers in Molecular Biosciences, vol. 9, 2022, p. 832393, https://doi.org/10.3389/fmolb.2022.832393.